Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
831
mi
from 43215
Tampa, FL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
430
mi
from 43215
Decatur, GA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
448
mi
from 43215
Stockbridge, GA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
448
mi
from 43215
Stockbridge, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
1508
mi
from 43215
Idaho Falls, ID
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
1508
mi
from 43215
Idaho Falls, ID
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
274
mi
from 43215
Chicago, IL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
481
mi
from 43215
New York, NY
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
6
mi
from 43215
Columbus, OH
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
6
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
844
mi
from 43215
Edmond, OK
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
844
mi
from 43215
Edmond, OK
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
508
mi
from 43215
Memphis, TN
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
991
mi
from 43215
Houston, TX
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
991
mi
from 43215
Houston, TX
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
1967
mi
from 43215
La Palma, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
1967
mi
from 43215
La Palma, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
1421
mi
from 43215
Las Cruces, NM
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
1421
mi
from 43215
Las Cruces, NM
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
5045
mi
from 43215
Rio de Janeiro,
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
5045
mi
from 43215
Rio de Janeiro,
Click here to add this to my saved trials
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/14/2015
The Institute for Clinical and Translational Science (ICTS)
1961
mi
from 43215
Irvine, CA
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/14/2015
The Institute for Clinical and Translational Science (ICTS)
1961
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/14/2015
Unversity of California, Irvine Healthcare, Dermatology, Gottschalk Medical Plaza
1962
mi
from 43215
Irvine, CA
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/14/2015
Unversity of California, Irvine Healthcare, Dermatology, Gottschalk Medical Plaza
1962
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Autoimmune Diseases
Status: Enrolling
Updated:  7/20/2015
Duke University Health System
354
mi
from 43215
Durham, NC
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Autoimmune Diseases
Status: Enrolling
Updated: 7/20/2015
Duke University Health System
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  8/31/2015
Wallace Rheumatic Study Center
1978
mi
from 43215
Los Angeles, CA
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 8/31/2015
Wallace Rheumatic Study Center
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  8/31/2015
Altoona Center for Clinical Research
244
mi
from 43215
Duncansville, PA
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 8/31/2015
Altoona Center for Clinical Research
244
mi
from 43215
Duncansville, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Abel Buchheim Pharmaceutical Research
995
mi
from 43215
Miami, FL
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Abel Buchheim Pharmaceutical Research
995
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Northwestern University School of Medicine
274
mi
from 43215
Chicago, IL
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Northwestern University School of Medicine
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Altoona Arthritis and Osteoporosis Center
mi
from 43215
Altoona, PA
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Altoona Arthritis and Osteoporosis Center
mi
from 43215
Altoona, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Metroplex Clinical Research Center
905
mi
from 43215
Dallas, TX
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Metroplex Clinical Research Center
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Levothyroxine in Pregnant SLE Patients
Pilot Double-Blind Placebo Controlled Trial of Levothyroxine in Pregnant Systemic Lupus Erythematosus (SLE) Patients With Autoimmune Thyroid Disease
Status: Enrolling
Updated:  9/9/2015
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Levothyroxine in Pregnant SLE Patients
Pilot Double-Blind Placebo Controlled Trial of Levothyroxine in Pregnant Systemic Lupus Erythematosus (SLE) Patients With Autoimmune Thyroid Disease
Status: Enrolling
Updated: 9/9/2015
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Autoimmunity in Sisters of Lupus Patients
Mapping Autoimmune Phenotypes in Multiplex Families (MADGC 2)
Status: Enrolling
Updated:  9/9/2015
The Feinstein Institute for Medical Research
494
mi
from 43215
Manhasset, NY
Autoimmunity in Sisters of Lupus Patients
Mapping Autoimmune Phenotypes in Multiplex Families (MADGC 2)
Status: Enrolling
Updated: 9/9/2015
The Feinstein Institute for Medical Research
494
mi
from 43215
Manhasset, NY
Click here to add this to my saved trials
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
1919
mi
from 43215
Loma Linda, CA
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
1919
mi
from 43215
Loma Linda, CA
Click here to add this to my saved trials
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
1919
mi
from 43215
Loma Linda, CA
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
1919
mi
from 43215
Loma Linda, CA
Click here to add this to my saved trials
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up
Status: Enrolling
Updated:  9/26/2015
National Institute of Environmental Health Sciences (NIEHS)
323
mi
from 43215
Bethesda, MD
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up
Status: Enrolling
Updated: 9/26/2015
National Institute of Environmental Health Sciences (NIEHS)
323
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
East Carolina University
429
mi
from 43215
Greenville, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
East Carolina University
429
mi
from 43215
Greenville, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Wake Medical Center
377
mi
from 43215
Raleigh, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Wake Medical Center
377
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
NIEHS, Research Triangle Park
352
mi
from 43215
Research Triangle Park, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
NIEHS, Research Triangle Park
352
mi
from 43215
Research Triangle Park, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Medical University of South Carolina
426
mi
from 43215
Columbia, SC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Medical University of South Carolina
426
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated:  9/26/2015
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated: 9/26/2015
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated:  9/26/2015
NIEHS, Research Triangle Park
352
mi
from 43215
Research Triangle Park, NC
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated: 9/26/2015
NIEHS, Research Triangle Park
352
mi
from 43215
Research Triangle Park, NC
Click here to add this to my saved trials
Lupus Genetics Studies
Lupus Genetic Studies; Lupus Family Registry & Repository
Status: Enrolling
Updated:  10/13/2015
Oklahoma Medical Research Foundation
848
mi
from 43215
Oklahoma City, OK
Lupus Genetics Studies
Lupus Genetic Studies; Lupus Family Registry & Repository
Status: Enrolling
Updated: 10/13/2015
Oklahoma Medical Research Foundation
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Genetic Study of Lupus Patients and Their Families
Gene Mapping in Women With SLE
Status: Enrolling
Updated:  10/13/2015
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Genetic Study of Lupus Patients and Their Families
Gene Mapping in Women With SLE
Status: Enrolling
Updated: 10/13/2015
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
506
mi
from 43215
Jonesboro, AR
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
506
mi
from 43215
Jonesboro, AR
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
1954
mi
from 43215
La Jolla, CA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
1954
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
1967
mi
from 43215
La Palma, CA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
1967
mi
from 43215
La Palma, CA
Click here to add this to my saved trials